<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-1S5OEDQ7/567b8e01-c5aa-4037-9e48-aad924b123c1/PDF"><dcterms:extent>217 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-1S5OEDQ7/3d67c119-1fe8-4d54-b2dc-87fc6878a763/TEXT"><dcterms:extent>30 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-1S5OEDQ7"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2019</dcterms:issued><dc:creator>Zidar, Nace</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:70</dc:format><dc:format xml:lang="sl">str. 43-49</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID_HOST:4721777</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-1S5OEDQ7</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Antibiotiki</dc:subject><dc:subject xml:lang="sl">bakterijska odpornost</dc:subject><dc:subject xml:lang="sl">Bakterijska rezistenca</dc:subject><dc:subject xml:lang="sl">izlivna črpalka</dc:subject><dc:subject xml:lang="sl">mutacija</dc:subject><dc:subject xml:lang="sl">protibakterijska učinkovina</dc:subject><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Mehanizmi razvoja bakterijske odpornosti na antibiotike| Understanding the mechanisms of antibiotic resistance|</dc:title><dc:description xml:lang="sl">Occurrence of resistance of the most prevalent bacterial pathogens to antibiotics is one of the major threats to public health. The main reasons for the lack of effective antibiotics have been the misuse of those agents and the unavailability of newer drugs. Bacteria adapt to antibiotics using two main strategies: with mutations of genes that are associated with the action of antibiotics or with the acquisition of foreign DNA coding for such genes. There are several mechanisms for the development of antibiotic resistance, which include prevention of access to drug targets, changes in the structure of antibiotic targets and direct modification of antibiotic structures. It is important to understand these mechanisms in order to successfully design new antibacterial drugs with a lower probability for resistance development. Because the terms have become interchangeable, for the purpose of this article, the term antibiotic is used as a synonym for an antibacterial drug</dc:description><dc:description xml:lang="sl">Hitro širjenje bakterijske odpornosti proti uveljavljenim antibiotikom predstavlja eno izmed največjih groženj za javno zdravje. Vzroki za pomanjkanje učinkovitih antibiotikov na trgu so v veliki meri povezani z njihovo neustrezno uporabo in manjšim številom novih odobrenih učinkovin. Bakterije lahko odpornost proti antibiotikom razvijejo na dva načina, z mutacijo genov, ki so povezani z delovanjem antibiotika, ali s privzemom tuje DNA, ki vsebuje zapis za gene, odgovorne za razvoj odpornosti. Obstaja več mehanizmov za razvoj odpornosti, med katere spadajo otežen dostop antibiotika do tarče, sprememba strukture tarče ali neposredna sprememba strukture antibiotika. Poznavanje teh mehanizmov je ključnega pomena za načrtovanje novih protibakterijskih učinkovin, pri uporabi katerih bi bil razvoj odpornosti manj verjeten. Zaradi splošne uveljavljenosti izraz antibiotik v članku uporabljamo kot sopomenko za protibakterijsko učinkovino</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-1S5OEDQ7"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-1S5OEDQ7" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-1S5OEDQ7/567b8e01-c5aa-4037-9e48-aad924b123c1/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-1S5OEDQ7/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-1S5OEDQ7" /></ore:Aggregation></rdf:RDF>